Synergistic Anti-Myeloma Activity of the Proteasome Inhibitor Marizomib and the IMiD(®) Immunomodulatory Drug Pomalidomide

The proteasome inhibitor bortezomib is an effective therapy for the treatment of relapsed and refractory multiple myeloma (RRMM); however, prolonged treatment can be associated with toxicity, peripheral neuropathy and drug resistance. Our earlier studies showed that the novel proteasome inhibitor ma...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Haematol
Huvudupphovsmän: Das, Deepika Sharma, Ray, Arghya, Song, Yan, Richardson, Paul, Trikha, Mohit, Chauhan, Dharminder, Anderson, Kenneth C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715649/
https://ncbi.nlm.nih.gov/pubmed/26456076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13780
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk